Why isn’t a drug taken off the market when a manufacturer gets a Warning Letter?
Warning Letters generally cause manufacturers to quickly and cooperatively correct problems. In some cases, this may mean that the product needs to be temporarily removed from the market or production must be stopped until the problem is resolved. In other cases, the problem may not require the manufacturer to stop its product from being sold. As with other product safety decisions, completely removing a product from the market, based on the problems justifying a Warning Letter, can also be dangerous to people who need the product. Warning Letters often help to solve product problems without having to remove necessary products from the market.
When necessary, for drug manufacturers who receive Warning Letters, FDA may withhold approval of a new drug from that manufacturer until identified manufacturing problems that may affect the new drug are corrected. In addition, for foreign drug manufacturers who receive Warning Letters, FDA may refuse to allow the manufacturer’s drug to be imported for sale in the United States until the problems that may affect the drug are corrected.
In cases when FDA finds that a manufacturer refuses to fix problems after receiving a Warning Letter, the agency can take additional measures to protect public health. For instance, FDA can quickly issue a press release or consumer alert to notify the public not to use the product. Additionally, FDA can take legal action to seize batches of a drug or to stop a company from further manufacturing and distributing the drug.
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- How FDA Evaluates Regulated Products: Drugs
- FDA Webinar on Prescription Drug Shortages
- FDA Webinar on "Bad Ads" Program
- FDA Basics Webinar on Generic Drugs
- FDA Basics Videos: Tim Coté on Orphan Drugs
- What is an FDA Drug Safety Communication?
- What is counterfeit medicine?
- FDA Basic Video: Interview with John Jenkins on New Drugs (Video)
- What are unapproved drugs and why are they on the market?
- How can I stay better informed about drugs? Is there a reliable website FDA recommends?
- How do I discard medicine that I no longer need, do I just throw it in the garbage?
- How do I report a bad reaction to medicine or medication error to FDA?
- Does FDA approve the proprietary names of prescription drugs?
- What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
- How does FDA help consumers when drug shortages happen?
- Does FDA approve the information given out by pharmacies when I pick up my medicine?
- How does FDA decide when a drug is not safe enough to stay on the market?
- How do I find out if a drug is approved? Is there a Web site I can go to?
- What is the approval process for a new prescription drug?
- What is a Warning Letter?
- Can FDA ban direct-to-consumer drug advertising?
How helpful was this information?